Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Living with asthma can be challenging. Unfortunately, there is no cure. But the good news is that there are effective treatments available to help manage this chronic respiratory condition. Two ...